AGA111

· Angitia Biopharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AGA111, covering 2022-10-10 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion [Phase 3]